VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PLMRPalomar Holdings, Inc.
$126.32$3.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksPLMRFinancials

Palomar Holdings, Inc. (PLMR) Financials

10Y historyFree accessUpdated daily

Palomar achieved aggressive top-line expansion with 59.7% year-over-year revenue growth in 2026Q1 while maintaining underwriting discipline through an 80.8% combined ratio.

PLMR Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16
Revenue977.99M875.97M553.86M375.93M327.09M247.79M168.46M113.3M72.97M59.47M42.7M
Revenue Growth %60.34%58.16%47.33%14.93%32%47.09%48.69%55.26%22.71%39.28%-
Medical Costs & Claims384.86M228.59M284.42M180.34M189.44M136.89M128.16M42.85M34.5M37.65M24.63M
Medical Cost Ratio %39.35%26.1%51.35%47.97%57.92%55.24%76.07%37.82%47.28%63.31%57.69%
Gross Profit593.13M647.37M269.45M195.59M137.64M110.9M40.31M70.44M38.47M21.82M18.06M
Gross Margin %60.65%73.9%48.65%52.03%42.08%44.76%23.93%62.18%52.72%36.69%42.31%
Gross Profit Growth %-140.26%37.76%42.1%24.11%175.14%-42.78%83.1%76.33%20.79%-
Operating Expenses339.99M393.98M118.25M91.95M70.09M53.76M34.08M52.37M20.26M16.89M11.79M
OpEx / Revenue %34.76%44.98%21.35%24.46%21.43%21.7%20.23%46.22%27.76%28.4%27.61%
Depreciation & Amortization10.28M8.87M5.11M4.5M4.12M3.54M1.34M216K212K160K88K
Combined Ratio %74.12%71.07%72.7%72.43%79.35%76.94%96.31%84.04%75.04%91.71%85.3%
Operating Income253.14M253.39M151.2M103.64M67.55M57.14M6.22M18.08M18.21M4.93M6.28M
Operating Margin %25.88%28.93%27.3%27.57%20.65%23.06%3.69%15.96%24.96%8.29%14.7%
Operating Income Growth %-67.59%45.88%53.43%18.22%818.17%-65.58%-0.75%269.58%-21.49%-
EBITDA266.8M262.26M156.3M108.14M71.67M60.68M7.56M18.29M18.43M5.09M6.37M
EBITDA Margin %27.28%29.94%28.22%28.77%21.91%24.49%4.49%16.15%25.25%8.56%14.91%
Interest Expense3.46M392K1.14M3.77M873K40K01.07M2.3M1.75M1.63M
Non-Operating Income-3.46M-392K-1.14M-3.77M-873K-40K0-1.07M-2.3M-1.75M-1.63M
Pretax Income253.14M253.39M151.2M103.64M67.55M57.14M6.22M18.08M18.21M4.93M6.28M
Pretax Margin %25.88%28.93%27.3%27.57%20.65%23.06%3.69%15.96%24.96%8.29%14.7%
Income Tax56.04M56.32M33.62M24.44M15.38M11.29M-34K7.46M-6K1.15M-337K
Effective Tax Rate %22.14%22.23%22.24%23.58%22.77%19.76%-0.55%41.25%-0.03%23.23%-5.37%
Net Income197.09M197.07M117.57M79.2M52.17M45.85M6.26M10.62M18.22M3.78M6.61M
Net Margin %20.15%22.5%21.23%21.07%15.95%18.5%3.71%9.37%24.97%6.36%15.49%
Net Income Growth %46.96%67.62%48.45%51.81%13.79%632.73%-41.09%-41.7%381.6%-42.8%-
EPS (Diluted)7.217.174.483.132.021.760.240.490.810.170.29
EPS Growth %43.31%60.04%43.13%54.95%14.77%633.33%-51.02%-39.51%376.47%-41.38%-
EPS (Basic)-7.404.613.192.071.800.250.490.810.170.29
Diluted Shares Outstanding27.34M27.49M26.22M25.33M25.8M26.11M25.6M21.83M22.63M22.63M22.63M

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrong
Balance SheetHealthy
Cash FlowRobust
Top Statement Risk

Catastrophe reinsurance market volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Aggressive Top-Line Expansion Continues

As reported in recent financial statements, Palomar achieved a 59.7% year-over-year revenue growth in 2026Q1, signaling that the company's strategic pivot toward casualty lines and the PLMR-Front platform is successfully capturing market share despite broader industry headwinds in the specialty property sector.

The consistent acceleration in revenue growth suggests that Palomar is effectively leveraging its data-driven underwriting to penetrate underserved niches. Investors should monitor whether this rapid scaling can be sustained without compromising the quality of the underlying risk portfolio as the company moves further into casualty segments.

Underwriting Discipline Amidst Rapid Scaling

Based on the provided quarterly data, Palomar maintained a combined ratio of 80.8% in 2026Q1, demonstrating that the company continues to generate significant underwriting profit even as it aggressively expands its footprint in non-traditional insurance lines and fee-based service offerings.

The ability to keep the combined ratio well below the 100% threshold indicates that the company's capital-light model remains highly efficient. This performance suggests that the ceding commissions earned from reinsurance partners are successfully offsetting acquisition costs, though the recent uptick in the loss ratio warrants further investigation into potential claims volatility.

Operational Efficiency Through Platform Scaling

According to the latest income statement figures, Palomar's operating income reached $53.5 million in 2026Q1, reflecting a scalable cost structure that benefits from the increasing contribution of the PLMR-Front platform relative to traditional, capital-intensive underwriting activities.

The company appears to be successfully decoupling its revenue growth from proportional increases in operating expenses, which is a hallmark of its platform-based strategy. This operational leverage suggests that management is effectively managing its broker network and administrative overhead while scaling its specialty insurance volume.

Sensitivity to Reinsurance Market Dynamics

While Palomar's underwriting results appear robust, the company's reliance on third-party reinsurance, as evidenced by the high volume of ceded premiums, creates a structural vulnerability to global reinsurance pricing cycles that could compress margins if capacity tightens unexpectedly.

The company's strategy of transferring tail risk is effective in benign environments but may face pressure if reinsurers increase treaty pricing or reduce coverage limits. Investors should remain cautious regarding the potential for margin contraction if the company is forced to retain more risk on its own balance sheet during a hard market cycle.

PLMR — Frequently Asked Questions

Quick answers to the most common questions about buying PLMR stock.

What was Palomar Holdings, Inc.'s (PLMR) revenue in 2025?

For fiscal year 2025, Palomar Holdings, Inc. (PLMR) reported total revenue of $876.0M. This represents a 1951.6% increase compared to $42.7M in 2016.

Is Palomar Holdings, Inc. (PLMR) profitable?

Palomar Holdings, Inc. (PLMR) is profitable, generating $197.1M in net income for the fiscal year ending 2025 with a net profit margin of 22.5%.

What is Palomar Holdings, Inc.'s operating profit margin?

Palomar Holdings, Inc. (PLMR) reported an operating income of $253.4M, resulting in an operating profit margin of 28.9%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Palomar Holdings, Inc.'s gross profit and gross margin?

Palomar Holdings, Inc. (PLMR) generated $647.4M in gross profit for the year, representing a gross profit margin of 73.9%. This demonstrates the company's core pricing power and production efficiency.